For information, Après-demain SA and Debiopharm Investment SA merged in March 2020.
2 September 2013
KeyLemon secures Series A Investment co-led by Debiopharm Investment and Swisscom ventures
17 January 2013
Debiopharm Group participates in first round of financing for compliant concept, an Empa and ETH Zurich spin-off bound for success…